Search by Prescriber
Search by Drug
Also known as: Rozlytrek
Find doctors, physicians, and providers who prescribe Entrectinib. Below you'll find the top prescribers based on Medicare Part D data.
ROZLYTREK is a kinase inhibitor indicated for the treatment of: adults with ROS1- positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test. ( 1.
This is not medical advice. Consult your healthcare provider.
| Prescriber↕ | Location↕ | Type↕ | Claims↓ | Beneficiaries↕ | Cost↕ |
|---|---|---|---|---|---|
| Wallace Akerley | Salt Lake City, UT | Medical Oncology | 16 | 0 | $183,569 |
| Laura Cannon | Salt Lake City, UT | Nurse Practitioner | 15 | 0 | $102,124 |
| Anh Pham | Duarte, CA | Hematology-Oncology | 14 | 0 | $277,130 |
| Aswini Padmanabhan | Baldwin Park, CA | Internal Medicine | 14 | 0 | $173,097 |
| Clifton Layman | El Paso, TX | Internal Medicine | 13 | 0 | $241,336 |
| Missak Haigentz | New Brunswick, NJ | Medical Oncology | 12 | 0 | $177,626 |
| Samir Alsawah | Port Huron, MI | Hematology-Oncology | 12 | 0 | $271,271 |
| Xiuning Le | Boston, MA | Internal Medicine | 12 | 0 | $181,802 |
| Gary Gordon | Elk Grove Village, IL | Hematology-Oncology | 12 | 0 | $149,354 |
| Andrea Teague | Albany, NY | Hematology-Oncology | 12 | 0 | $145,776 |
| Jeremy Cetnar | Portland, OR | Medical Oncology | 12 | 0 | $178,533 |
| Charles Lu | Houston, TX | Medical Oncology | 12 | 0 | $303,637 |
| Pedro Solivan Ortiz | Rio Piedras, PR | Hematology-Oncology | 11 | 0 | $213,957 |
| Gaurav Trikha | St Augustine, FL | Hematology-Oncology | 11 | 0 | $73,653 |
| Mabel Ryder | Rochester, MN | Endocrinology | 11 | 0 | $129,946 |
| Gregory Kalemkerian | Ann Arbor, MI | Medical Oncology | 11 | 0 | $189,215 |
| Kumud Rangaraj | Cumming, GA | Hematology-Oncology | 11 | 0 | $236,224 |
| Alan Trumbly | Richardson, TX | Hematology-Oncology | 11 | 0 | $76,646 |
| Sai-Hong I Ou | Orange, CA | Internal Medicine | 11 | 0 | $199,434 |